Early Timing of the Use of Paricalcitol for the Treatment of Secondary Hyperparathyroidism (Shpt) in Chronic Kidney Patients (Ckd): A Budget Impact Analysis (Bi)
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1695
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2014
Authors
Publisher
Elsevier BV